Atlas Trials

Pilot Study of Expanded , Activated Haploidentical Natural Killer Cell Infusions for Sarcomas

Clinical trial NCT02409576 · UNKNOWN

Trial details

NCT number
NCT02409576
Sponsor
National University Hospital, Singapore
Status
UNKNOWN
Phase
Phase 1, Phase 2
Study type
INTERVENTIONAL
Ewing SarcomaRhabdomyosarcoma
Start date
2015-02-01
Primary completion
2020-08-01
Enrollment
20

View on ClinicalTrials.gov

Track trials programmatically

Sponsors, conditions and status changes through the Atlas API.